Disease-Modifying Targets in Neurodegenerative Disorders: Paving the Way for Disease-Modifying Therapies
Editat de Veerle Baekelandt, Evy Lobbestaelen Limba Engleză Hardback – apr 2017
This overview is ideal for neuroscientists, biomedical researchers, medical doctors, and caregivers, not only providing readers with a summary of the way patients are treated today, but also offering a glance at the future of neurodegenerative disorder treatment.
- Provides a comprehensive overview of how key proteins in neurodegenerative disorders can be used as targets to modify disease progress
- Summarizes how patients are treated today, providing a glance at future disease management
- Includes intelligible and informative information that is perfect for non-specialists, medical practitioners, and scientists
- Written and peer reviewed by outstanding scientists in their respective fields
Preț: 434.39 lei
Preț vechi: 457.24 lei
-5% Nou
Puncte Express: 652
Preț estimativ în valută:
83.14€ • 86.47$ • 69.67£
83.14€ • 86.47$ • 69.67£
Carte tipărită la comandă
Livrare economică 07-21 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780128051207
ISBN-10: 0128051205
Pagini: 320
Dimensiuni: 191 x 235 x 23 mm
Greutate: 0.76 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0128051205
Pagini: 320
Dimensiuni: 191 x 235 x 23 mm
Greutate: 0.76 kg
Editura: ELSEVIER SCIENCE
Cuprins
1. The multitude of therapeutic targets in neurodegenerative proteinopathies
2. Synuclein misfolding as a therapeutic target
3. Neuroinflammation as a therapeutic target in neurodegenerative diseases
4A. Stem cells in neurodegeneration: mind the gap
4B. The potential of stem cells in tackling neurodegenerative diseases
5. Preclinical models of Alzheimer’s disease for identification and preclinical validation of therapeutic targets: from fine-tuning strategies for validated targets to new venues for therapy
6. Parkinson’s disease
7. Lewy body dementia
8. Frontotemporal dementia
9. From huntingtin gene to Huntington’s disease-altering strategies
10. Amyotrophic lateral sclerosis: mechanisms and therapeutic strategies
2. Synuclein misfolding as a therapeutic target
3. Neuroinflammation as a therapeutic target in neurodegenerative diseases
4A. Stem cells in neurodegeneration: mind the gap
4B. The potential of stem cells in tackling neurodegenerative diseases
5. Preclinical models of Alzheimer’s disease for identification and preclinical validation of therapeutic targets: from fine-tuning strategies for validated targets to new venues for therapy
6. Parkinson’s disease
7. Lewy body dementia
8. Frontotemporal dementia
9. From huntingtin gene to Huntington’s disease-altering strategies
10. Amyotrophic lateral sclerosis: mechanisms and therapeutic strategies